Skip to main content

Effect of 6 months of growth hormone treatment in young children with Prader—Willi syndrome

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Nine prepubertal children with Prader—Willi syndrome were treated with growth hormone (GH; 24 IU/m2/week) for 6 months. Mean height increased by 0.8 SD and mean weight for height decreased by 0.7 SD over this 6‐month treatment period. Body fat, measured by dual‐energy X‐ray absorptiometry, decreased by 22.5% over the period of GH treatment, whereas fat‐free mass increased by 14%. These preliminary results indicate that GH is effective in increasing height and normalizing body composition in patients with Prader—Willi syndrome. □ Body composition, growth hormone treatment, Prader—Willi syndrome, growth

Document Type: Short Communication

DOI: http://dx.doi.org/10.1111/j.1651-2227.1997.tb18374.x

Affiliations: 1: Centre for Adolescent Medicine, Zurich, Switzerland 2: Department of Medical Radiology, Nuclear Medicine, Zurich University, Zurich, Switzerland

Publication date: November 1, 1997

bpl/apa/1997/00000086/A423s423/art00015
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more